Stanescu, Sinziana http://orcid.org/0000-0003-0340-4580
Belanger-Quintana, Amaya
Fernandez-Felix, Borja Manuel
Ruiz-Sala, Pedro
del Valle, Mercedes
Garcia, Fernando
Arrieta, Francisco
Martinez-Pardo, Mercedes
Funding for this research was provided by:
Fundación Ramón Areces (CIVP17A2827)
Article History
Received: 14 September 2021
Accepted: 17 January 2022
First Online: 30 January 2022
Declarations
:
: SS has received travel and speaker fees from Nutricia, Mead Johnson, Genzyme, Recordatti Rare Diseases, Vitaflo-Nestlé, BioMarin. ABQ has received travel and speaker fees from Nutricia, Mead Johnson, Genzyme, Recordati Rare Diseases, Vitaflo-Nestlé, Takeda, BioMarin; advisory fees from BioMarin and Merk Serono. FA has received travel and speaker fees from Nutricia, Mead Johnson, Recordati Rare Diseases, Vitaflo-Nestlé, BioMarin.PRS declares that she has no conflict of interest. MV declares that she has no conflict of interest. FG declares that she has no conflict of interest. BMFF declares that he has no conflict of interest. MMP has received travel and speaker fees from Nutricia, Mead Johnson, Genzyme, Recordati Rare Diseases, Vitaflo-Nestlé, Takeda, BioMarin; advisory fees from BioMarin and Merk Serono.
: The study was approved by the Ethic Committee of Hospital Ramon y Cajal (Madrid, Spain).
: Written informed consent to be include in this study and for publication was provided by the patients and their parents.